Similarly, SPHK inhibitors alone did not affect the survival of CLL cells that came from aCD3+DMSO cultures but promoted the cell death induced by venetoclax (Figure 4D). Here, SPHK1 is linked to B-cell chronic lymphocytic leukemia.